- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Zydus Lifesciences Limited — Updates, 14-05-2025: Press Release
14-05-2025 | 12:45 pm
14-05-2025 | 12:45 pm
Zydus Lifesciences has announced a board meeting on the financial results for the quarter and half-year. Its Ambernath API manufacturing facility received a No Action Indicated (NAI) report from the USFDA after inspection, signaling strong regulatory compliance with zero observations. This clearance reinforces operational stability and boosts confidence in Zydus’s manufacturing strength and business outlook.
No comments yet. Be the first to comment!